Trial intelligence / Profile preview

Topical Diclofenac Gel in Superficial Thrombophlebitis

NCT00377806Phase 4Completed

Sponsor
Novartis
Start
Jan 2003
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in superficial thrombophlebitis (SVT) comparing Diclofenac Gel with Placebo (2 arms). Primary endpoint: Area Under the Curve of the Symptom Score. Started Jan 2003; status: completed.

02

Drugs

diclofenac
03

Conditions

superficial thrombophlebitis (SVT)

Beyond the preview

Go deeper on NCT00377806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00377806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call